calmidazolium has been researched along with Active Hyperemia in 1 studies
calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.
Excerpt | Relevance | Reference |
---|---|---|
"In reactive hyperemia in the hindlimb, the peak flow did not differ; however, both the repayment flow and the duration were significantly larger in pulsatile flow." | 1.31 | Pulsatile flow enhances endothelium-derived nitric oxide release in the peripheral vasculature. ( Nagano, I; Nakano, T; Okabe, H; Tominaga, R; Yasui, H, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakano, T | 1 |
Tominaga, R | 1 |
Nagano, I | 1 |
Okabe, H | 1 |
Yasui, H | 1 |
1 other study available for calmidazolium and Active Hyperemia
Article | Year |
---|---|
Pulsatile flow enhances endothelium-derived nitric oxide release in the peripheral vasculature.
Topics: Angiotensin II; Animals; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; C | 2000 |